|
Demographic characteristics
|
|
Age, mean ± SD
|
63.3 ± 10.8
|
64.4 ± 10.6
|
0.246
|
|
Male
|
165 (65.0)
|
155 (63.0)
|
0.649
|
|
Body mass index, mean ± SD
|
25.20 ± 3.87
|
25.44 ± 3.81
|
0.475
|
|
NYHA class
|
0.059
|
|
I
|
39 (15.4)
|
22 (8.9)
|
0.029
|
|
П
|
121 (47.6)
|
116 (47.2)
|
0.914
|
|
Ш
|
84 (33.1)
|
102 (41.5)
|
0.052
|
|
IV
|
10 (3.9)
|
6 (2.4)
|
0.354
|
|
Echocardiogram
|
254
|
245
| |
|
Ejection fraction (%)
|
56.7 ± 3.3
|
57.1 ± 3.6
|
0.564
|
|
Coronary artery disease
|
0.383
|
|
Single-vessel
|
13 (5.1)
|
6 (2.4)
|
0.117
|
|
Double-vessel
|
41 (16.1)
|
41 (16.7)
|
0.874
|
|
Triple-vessel
|
84 (33.1)
|
76 (30.9)
|
0.602
|
|
Not investigated
|
116 (45.7)
|
123 (50.0)
|
0.332
|
|
Combined diseases
|
|
Diabetes
|
82 (32.3)
|
68 (27.6)
|
0.258
|
|
Hypertension
|
139 (54.7)
|
135 (54.9)
|
0.972
|
|
COPD
|
3 (1.2)
|
6 (2.4)
|
0.332
|
|
Hemofiltration or dialysis
|
0
|
5 (2.0)
|
0.028
|
|
Cerebrovascular accident /transient ischemic attack
|
1 (0.4)
|
3 (1.2)
|
0.366
|
|
Preoperative Hemoglobin g/L, mean ± SD
|
114.99 ± 16.55
|
114.02 ± 19.99
|
0.555
|
|
Drugs taken
|
|
β-Receptor blocker
|
45 (17.7)
|
53 (21.5)
|
0.281
|
|
ACEI
|
37 (14.6)
|
32 (13.0)
|
0.613
|
|
Calcium antagonist
|
28 (11.0%)
|
36 (14.6)
|
0.227
|
|
Aprotinin
|
119 (46.9)
|
117 (47.6)
|
0.874
|
|
Others
|
39 (15.4)
|
30 (12.2)
|
0.306
|
|
Type of surgery
|
0.379
|
|
Cardiac surgery (Coronary artery bypass graft)
|
110 (43.3)
|
97 (39.4)
| |
|
Non-cardiac surgery
|
144 (56.7)
|
149 (60.6)
| |
|
Hepatobiliary surgery
|
37 (26.4)
|
32 (21.5)
|
0.613
|
|
Gastrointestinal surgery
|
48 (30.7)
|
50 (33.6)
|
0.688
|
|
Gynecological surgery
|
39 (23.2)
|
36 (24.2)
|
0.822
|
|
Urinary surgery
|
20 (19.7)
|
31 (20.1)
|
0.081
|
